Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-29

Clinical Trial Update: Vasopressin and V2 Receptor in Meniere's Disease [NA]

View source ↗

Summary

This clinical trial update notes the completion of a study from Osaka University investigating the role of vasopressin and the V2 receptor in Ménière's disease …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VASOPRESSIN (VASOPRESSIN)

Snippet

Sponsor: Osaka University | Conditions: Meniere Disease | NA | Status: COMPLETED